Small Pharma's IP Portfolio Grows With Numerous Approved Patent Applications Around The World
Portfolio Pulse from Lara Goldstein
UK-based Small Pharma Inc. (OTCQB: DMTTF) has expanded its IP portfolio with numerous approved patent applications in North America, Australasia, and Europe. The company's psychedelic IP portfolio now consists of 14 granted patents with 87 granted or pending.
May 26, 2023 | 3:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Small Pharma Inc. has expanded its IP portfolio with numerous approved patent applications, strengthening its position in key international markets.
The expansion of Small Pharma's IP portfolio with numerous approved patent applications in key international markets is likely to have a positive impact on the company's stock price in the short term. The increased IP protection will help optimize the commercial potential of their pipeline programs, which could attract more investors and increase the company's valuation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100